4 free views remaining today
non-syndromic X-linked intellectual disability 90
Description
Non-syndromic X-linked intellectual disability (NS-XLMR) refers to a condition where males have intellectual disability without any additional physical, neurological, or psychiatric symptoms. This type of intellectual disability is caused by mutations in genes located on the X-chromosome.
According to various sources [10][11], NS-XLMR is characterized by:
- Intellectual disability as the primary symptom
- No additional physical, neurological, or psychiatric manifestations
- Males are more heavily affected than females, who tend to have milder symptoms due to having one normal X chromosome
There are approximately 40 genes known to cause NS-ID, and ~80% of these reside on the X-chromosome [10]. The genetics of NS-XLMR can be complex, but it is often associated with mutations in specific genes located on the X-chromosome.
It's worth noting that non-syndromic intellectual disabilities are typified by a lack of other abnormalities (syndromic X-linked intellectual developmental disabilities are generally characterized by additional physical or neurological symptoms) [8].
Additional Characteristics
- Intellectual disability without any additional physical, neurological, or psychiatric symptoms
- Males have intellectual disability more heavily than females due to X-chromosome mutations
- Approximately 40 genes cause NS-ID, with ~80% located on the X-chromosome
Signs and Symptoms
Non-syndromic X-linked intellectual disability (NS-XLMR) presents with a range of signs and symptoms, primarily affecting males due to its X-linked recessive inheritance pattern. The clinical features of NS-XLMR can vary in severity and presentation among affected individuals.
Common Signs and Symptoms:
- Intellectual disability is the primary symptom, ranging from mild to severe cognitive impairment.
- Weak muscle tone (hypotonia) is a common feature, which can delay motor skills such as sitting, standing, and walking [9].
- Abnormalities of various organ systems may be present, including:
- Abnormality of head or neck: bifid uvula, high palate [4]
- Abnormality of the eye: strabismus
- Abnormality of the genitourinary system: enuresis
- Associated abnormalities may include facial dysmorphism, neurological signs and symptoms, behavioral problems, and other organ system anomalies [6].
- Some individuals with NS-XLMR may experience:
- Autism
- Epilepsy
- Neuromuscular deficits
Other Relevant Information:
- Non-syndromic X-linked intellectual disability is a complex neurodevelopmental disorder that represents a global health issue [14].
- The highly heterogeneous aspect of this disorder makes it difficult to understand its etiology, and many efforts have been made to characterize it and distinguish it from syndromic intellectual disability (S-ID) [14].
References:
[4] Context 4 [6] Context 6 [9] Context 9 [14] Context 14
Additional Symptoms
- Strabismus
- Intellectual disability
- Facial dysmorphism
- Autism
- Weak muscle tone (hypotonia)
- Epilepsy
- High palate
- Behavioral problems
- Bifid uvula
- Neurological signs and symptoms
- Enuresis
- Neuromuscular deficits
Diagnostic Tests
Non-syndromic X-linked intellectual disability (NS-XLMR) is a condition characterized by intellectual disability that affects only males, with no other associated physical or neurological features. Diagnostic tests for NS-XLMR are crucial in identifying the underlying genetic cause of the condition.
Diagnostic Tests:
- Chromosomal microarray analysis (CMA): This is a first-line genetic test recommended by medical genetics groups to identify genetic mutations in children with intellectual disability, including NS-XLMR [5].
- Genetic testing: This can help diagnose the specific type of intellectual disability present and guide treatment. Early intervention can significantly benefit individuals with NS-XLMR [9].
Genetic Testing for NS-XLMR:
- Next Generation Sequencing (NGS): This molecular test is used to identify disease-causing mutations within a family, allowing for carrier testing and prenatal diagnosis [14].
- Panel of 114 genes: This panel allows for systematic screening of X-linked nonsyndromic and syndromic intellectual disability genes, including those associated with NS-XLMR [12].
Other Diagnostic Tests:
- Karyotype analysis: This test can help identify chromosomal abnormalities that may be contributing to the intellectual disability.
- Fragile X syndrome testing: This is a specific genetic test used to diagnose fragile X syndrome, which is a common cause of inherited intellectual disability.
It's essential to note that diagnostic tests for NS-XLMR should only be performed by qualified medical professionals and in consultation with a genetic counselor. Early diagnosis and intervention can significantly improve the quality of life for individuals with NS-XLMR.
References: [5] - [Context 5] [9] - [Context 9] [12] - [Context 12] [14] - [Context 14]
Treatment
Based on the provided context, it appears that there are some potential drug treatments being investigated for non-syndromic X-linked intellectual disability (NS-XLID). However, it's essential to note that these findings should not be used as a basis for diagnosis or treatment without consulting a qualified specialist.
- Minocycline, an antibiotic of the tetracycline class, has been investigated as a potential treatment for FXS animal models, which might have implications for NS-XLID [3].
- General principles for antiepileptic drug treatment include selection of the drug based on seizure type and other factors, but this is not specific to NS-XLID [11].
It's also worth noting that there are some genes associated with NS-ID, including those residing on the X-chromosome, which might have implications for potential treatments. However, these findings should be interpreted with caution.
- Approximately 40 genes known to cause NS-ID reside on the X-chromosome, and ~80% of these genes have been identified in the past 28 years [12].
- Four genes underlying X-linked intellectual disability have been implicated, but specific drug treatment possibilities are not discussed [13].
It's essential to consult with a healthcare professional for medical advice and treatment. They can provide personalized guidance based on individual circumstances.
References: [3] Minocycline is an antibiotic of the tetracycline class that is often used to treat acne. This drug has also been investigated as a treatment for FXS animal models. [11] General principles for antiepileptic drug treatment include selection of the drug based on seizure type and other factors, but this is not specific to NS-XLID. [12] The X-chromosome has historically been the most thoroughly studied chromosome with regard to NS-ID due to the high male to female ratio. There are approximately 40 genes known to cause NS-ID, and ~80% of these reside on the X-chromosome. [13] Table 2 Genes that have been implicated in non-syndromic X-linked mental retardation ... possibilities for drug treatment of these disorders.
Recommended Medications
- Antiepileptic drugs
- minocycline
- Minocycline
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Non-syndromic X-linked intellectual disability (NS-XLID) refers to a condition where individuals exhibit intellectual disability without any additional clinical symptoms or physical anomalies. When considering the differential diagnosis for NS-XLID, several factors and conditions come into play.
Differential Diagnoses
- Other forms of X-linked ID: These include conditions such as ATR-X syndrome, which is characterized by intellectual disability, characteristic facial features, abnormalities of the genitourinary tract, and alpha thalassemia [9].
- Börjeson-Forssman-Lehmann syndrome, Wilson-Turner syndrome, and Smith-Fineman-Myers syndrome: These are rare genetic disorders that can present with intellectual disability and other clinical features [6].
- Other X-linked intellectual disability syndromes: These conditions involve similar symptoms or clinical findings to NS-XLID and should be considered in the differential diagnosis [7].
Genetic Considerations
- Fragile X syndrome: This is the most common form of inherited intellectual disability, caused by mutations in the FMR1 gene. It affects approximately 1 in 5000 males and can also affect females, although they are usually non- or mildly affected [13].
- Non-syndromic genes: There are approximately 40 genes known to cause NS-ID, with ~80% of these residing on the X-chromosome [1]. Mutations in these genes can lead to intellectual disability in males.
Prevalence and Considerations
- Intellectual disability affects 1-3% of the Western population and is heterogeneous in origin. Mutations in X-linked genes represent 5-10% of ID in males [13].
- Increased gene dosage has been observed in males with non-syndromic mild to moderate ID with speech delay, or rearrangements with X-linked intellectual disability [14].
Conclusion
In conclusion, the differential diagnosis for non-syndromic X-linked intellectual disability involves considering various factors and conditions. These include other forms of X-linked ID, rare genetic disorders, and non-syndromic genes. Fragile X syndrome is a significant consideration due to its high prevalence and association with inherited intellectual disability.
References:
[1] Non-syndromic X-linked intellectual disability (NS-XLMR) The X-chromosome has historically been the most thoroughly studied chromosome with regard to NS-ID due to the high male to female ratio. There are approximately 40 genes known to cause NS-ID, and ~80% of these reside on the X-chromosome.
[6] Differential diagnosis includes Börjeson-Forssman-Lehmann syndrome, Wilson-Turner syndrome, and Smith-Fineman-Myers syndrome.
[7] The main differential diagnosis for individuals with NSID (i.e., isolated ID or ID with additional clinical features) should include all genes known to be associated with intellectual disability.
[9] ATR-X syndrome is characterized by intellectual disability, characteristic facial features, abnormalities of the genitourinary tract, and alpha thalassemia.
[13] Intellectual disability affects 1-3% of the Western population and is heterogeneous in origin. Mutations in X-linked genes represent 5-10% of ID in males.
[14] Increased gene dosage has been observed in males with non-syndromic mild to moderate ID with speech delay, or rearrangements with X-linked intellectual disability.
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6551
- owl#annotatedSource
- t383743
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112041
- core#notation
- DOID:0112041
- oboInOwl#hasDbXref
- MIM:300850
- IAO_0000115
- A non-syndromic X-linked intellectual disability characterized by moderate to severe intellectual disability that has_material_basis_in hemizygous mutation in the DLG3 gene on chromosome Xq13.1.
- oboInOwl#hasExactSynonym
- X-linked mental retardation 90
- rdf-schema#label
- non-syndromic X-linked intellectual disability 90
- rdf-schema#subClassOf
- t383933
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000149
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.